Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Form of Underwriting Agreement
- 3.6 Certificate of Amendment to Amended and Restated Certificate
- 4.1 Form of Representatives Warrant Agreement
- 10.11 Consent
- 10.12 Form of Lock Up Agreement
- 23.1 Consent
- 99.1 Audit Committee Charter
- 99.2 Compensation Committee Charter
- 99.3 Nominating and Corporate Governance Committee Charter
- 99.4 Code of Ethics
- 99.7 Consent of Heidi Skolnik
- EX-FILING FEES.107 Filing Fee
- Download Excel data file
- View Excel data file
Associated filings
- 28 Jun 23 RW Registration withdrawal request
-
9 Jan 23 S-1/A IPO registration (amended)
- 2 Sep 22 S-1/A IPO registration (amended)
- 5 Aug 22 S-1/A IPO registration (amended)
- 31 May 22 S-1 IPO registration
GLUC similar filings
Filing view
External links
EXHIBIT 99.7
CONSENT OF DIRECTOR NOMINEE
In connection with the filing by Glucose Health, Inc. (the “Company”) of a Registration Statement on Form S-1 (together with any amendments or supplements thereto, the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby consents, as required by Rule 438 under the Securities Act, to being named in the Registration Statement as a Director Nominee.
October 17, 2022
By: | /s/ Heidi Skolnik |
|
Name: | Heidi Skolnik |
|